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Abstract
During the last two decades, genotyping technology has advanced rapidly, which en-
abled the tremendous success of genome-wide association studies (GWAS) in the search
of disease susceptibility loci (DSLs). However, only a small fraction of the overall pre-
dicted heritability can be explained by the DSLs discovered. One possible explanation
for this ”missing heritability” phenomenon is that many causal variants are rare. The re-
cent development of high-throughput next-generation sequencing (NGS) technology pro-
vides the instrument to look closely at these rare variants with precision and efficiency.
However, new approaches for both the storage and analysis of sequencing data are in
imminent needs.
In this thesis, we introduce three methods that could be utilized in the management
and analysis of sequencing data. In Chapter 1, we propose a novel and simple algo-
rithm for compressing sequencing data that leverages on the scarcity of rare variant data,
which enables the storage and analysis of sequencing data efficiently in current hardware
environment. We also provide a C++ implementation that supports direct and parallel
loading of the compressed format without requiring extra time for decompression.
Chapter 2 and 3 focus on the association analysis of sequencing data in population-
based design. In Chapter 2, we present a statistical methodology that allows the iden-
tification of genetic outliers to obtain a genetically homogeneous subpopulation, which
reduces the false positives due to population substructure. Our approach is computa-
tionally efficient that can be applied to all the genetic loci in the data and does not re-
quire pruning of variants in linkage disequilibrium (LD). In Chapter 3, we propose a gen-
eral analysis framework in which thousands of genetic loci can be tested simultaneously
for association with complex phenotypes. The approach is built on spatial-clustering
iii
methodology, assuming that genetic loci that are associated with the target phenotype
cluster in certain genomic regions. In contrast to standard methodology for multi-loci
analysis, which has focused on the dimension reduction of data, the proposed approach
profits from the availability of large numbers of genetic loci. Thus it will be especially rel-
evant for whole-genome sequencing studies which commonly record several thousand
loci per gene.
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Handling the data management needs of high-throughput
sequencing data: SpeedGene, a compression algorithm for
the efficient storage of genetic data
Dandi Qiao, Wai-Ki Yip, Christoph Lange
Department of Biostatistics, Harvard School of Public Health, Boston,
MA, USA
1.1 Introduction
As the influx of high-throughput sequencing data [The 1000 Genome Project Consor-
tium, 2010], [Bansal et al., 2010], [Metzker, 2010] is imminent, the data management
requirements for the analysis packages have changed fundamentally. While, during the
days of candidate gene analysis and linkage analysis, ”only” up to several thousands of
genetic loci had to be stored and loaded into the analysis packages, current Genome-wide
Association studies (GWAS) provide genetic information on several millions of genetic
loci. Thus, the typical size of a dataset containing mostly common variants is about 1
to 30 Gigabytes. For high-throughput sequencing studies, the number of genetic loci
genotyped increases by several magnitudes, and the file size of such sequencing data can
be up to several Terabytes. For such large files, the loading process can take up to few
hours without counting the time for analysis. This results in great waste of disk space
and computation time, which is a problem that is encountered routinely.
One possible solution is to use the general-purpose compression software, such as Gzip
and BGZip. However, such compression software is not designed specifically for genetic
data and its analysis, so the compression rate is relatively low and decompression is
always needed before accessing the data. Better solutions have been proposed. PLINK
and PBAT, which are free whole-genome association analysis toolsets, have introduced
Binary PED formats [Lange et al., 2004] [Purcell et al., 2007]. This format ensures
that only 2 Bits are required for storing the information of one genotype. It is the
most popular compression format used in GWAS. However, the compression rate is
not sufficient for massive datasets generated nowadays as their compressed datasets
could still occupy several Gigabytes of the disk space. In recent years, sophisticated
compression techniques designed specifically for sequencing data have been proposed.
For example, DNAzip [Christley et al., 2009] introduced the idea of storing only the
difference between one individual genome data and a reference genome. However, such
algorithms suffer the large overhead for storing the reference genome. Also, they require
substantial CPU-time for decompression.
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We propose here a simple and efficient algorithm to store large datasets containing
SNP data of multiple samples. We show that our algorithm always works better than
the compression algorithm implemented in PLINK or PBAT and provides excellent
compression rate for sequencing data. Also, the compressed data structure provides the
potential for efficient implementation of permutation methods and does not require any
overhead CPU-time for decompression. We have implemented the algorithm in the GPL
licensed C++ library: SpeedGene. We show that it takes much less time for loading the
compressed files than PLINK using our library. In addition, Our C++ implementation
supports parallel loading of the genetic information, which further decreases the loading
time as the number of parallel jobs increases. The version 1.0 of the SpeedGene library
is available at http://people.hsph.harvard.edu/˜dqiao/SpeedGene.html
together with detailed instructions and examples.
1.2 Methods
1.2.1 The LINKAGE/PLINK data format
The LINKAGE or PLINK data format is a commonly used data format for storing SNP
data in Genome-Wide Association studies. Data files in this format is called pedigree files
and have ”.ped” as the suffix. This format can be converted from or to the VCF format
used in 1000 Genome Project using VCFtools [Danecek et al., 2011]. The SpeedGene
library currently only recognizes pedigree files in the LINKAGE/PLINK format, but
the algorithm can be implemented for compressing SNP data in the VCF format. The
VCF format requires the same amount of disk space for each genotype (4 Bytes) as the
LINKAGE/PLINK format, so the compression rate of this algorithm applying on VCF
files should be similar to the compression rate for pedigree files. Note that VCF files may
contain other informations such as Indels, Deletions, and the phase information, which
could not be incorporated into the LINKAGE format. However, since SNP data are
very commonly used genetic data in association studies and takes the most disk space,
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efficient storage of the SNP data could still save a lot of resources. In the demonstration
of the algorithm and the examples below, we use the LINKAGE/PLINK format as the
input format.
Figure 1.1: A toy example of a pedigree file in the LINKAGE format. The first line con-
tains the marker names. Starting from the second line, each line contains the pedigree
and genetic information for each individual. The first six columns indicate the subject’s
pedigree ID, subject ID, father ID, mother ID, sex and affection status. The other columns
contain the genetic data.
Any pedigree file in the LINKAGE format has the same structure, a toy example is shown
in Figure 1.1. The first line contains the marker names, separated by a space character.
Starting from the second line, each line includes pedigree and genetic information for
each individual. The first six columns of these lines specify each individual’s pedigree
information in the order of pedigree ID, subject ID, father ID, mother ID, sex, and affec-
tion status. Subject ID must be unique within one’s family. Father and mother ID could
be 0 if this information is unknown, e.g. population-based study of unrelated subjects.
Sex is 1 for male and 2 for female. Affection status is 1 if the subject is unaffected, 2 if
affected, and 0 if the status is unknown. The other columns contain the genetic data for
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each individual, separated by a space between each marker. Two columns are required
to represent the information for two alleles, separated by a space. The allele information
is coded using 0 to 4 where 1 = A, 2 = C, 3 = G, 4 = T and 0 represents missing allele
information.
1.2.2 The SpeedGene Algorithm
The SpeedGene algorithm consists of three different sub-algorithms, which are selected
by SpeedGene based on the minor allele frequency (MAF) of the genetic locus to be stored.
The space needed for the compressed data is computed for the sub-algorithms before-
hand. The SpeedGene algorithm then selects the best procedure among the three com-
pression methods. The first sub-algorithm is based on the binary format implemented
in PLINK and PBAT. It utilizes the fact that the marker information of each marker can
be represented using a 2-digit binary number. The second sub-algorithm uses subject
indices to indicate heterogeneous, homogeneous and missing genotypes. The third sub-
algorithm uses binary digits to indicate heterogeneous genotype and subject indices to
indicate homozygous and missing genotypes. A feature of all three compression meth-
ods is that the required memory space for storage can be computed prior to compression.
Thereby, the SpeedGene algorithm is able to select the optimal method before compress-
ing the data. The three sub-algorithms are described in detail in the following sections.
Sub-algorithm I: Compression using binary encoding
For any pedigree file, we assume that there are only bi-allelic markers in the file. For
any allele of a marker, an individual may only have 0, 1 or 2 of this allele. Also, the
allele information can be missing for any individual at any marker. Thus, the marker
information can be transformed into the number of copies of a particular allele. It
could be 0,1,2, or missing and could be converted to a 2-digit binary number. In the
compression process, we find the minor alleles at each marker and use 00, 01, 10 to
represent zero, one or two copies of the minor allele at one marker. 11 indicate that the
genetic information is missing at this marker for the individual. Thus, one genotype in
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the original file can be converted into two binary digits, which is 2 Bits on disk space.
Four of such 2-digit binary number is 8 Bits, which equals 1 Byte. Therefore, the genetic
information of four markers for one individual can be converted into 1 Byte in a binary
file. This binary encoding is similar to the binary format used in PLINK [Purcell et al.,
2007] or PBAT [Lange et al., 2004].
Based on this conversion method, we can compress the genetic information in the pedi-
gree file into a much smaller binary file. As we have seen in the example (Figure 1.2), the
genetic information for four genotypes occupies 16 Bytes in the original pedigree file, and
it is converted to only 1 Byte in the compressed file, which could save up to a factor of
sixteen on the disk space. If there are n subjects in the dataset, the storage requirement
for compressing n genotypes for one marker using this algorithm is given by
d2 ∗ n/8e Bytes (1.1)
For the assessment of the performance of the proposed SpeedGene algorithm, we will use
the LINKAGE/PLINK format and the binary-encoding algorithm described above as the
standard approach to which the SpeedGene algorithm will be compared.
Sub-algorithm II: Compression using subject indices
With the binary-encoding algorithm described above, the genetic information of any
marker in one dataset is compressed to the same size since the compression algorithm
does not depend on the frequency of each genotype. As we will see later, the performance
of the binary compression is the best we can achieve when the variants are relatively
common (MAF > 30%). However, for SNPs with small MAF, only a few subjects
have the heterozygous genotype and, even fewer, have the rare homozygous genotype.
Thus, it is wasting disk space if the genetic information for all the subjects is recorded,
especially for the subjects with the common homozygous genotypes which is by far
the most frequent genotype. Therefore, we can utilize this feature of SNPs with small
MAF, and record only the indices of the subjects with the missing, heterozygous or rare
homozygous genotypes for the SNP. The common homozygous genotype is the default
6
Figure 1.2: Genetic information of the first four markers for the first three individuals in
the toy example is extracted here to demonstrate the sub-algorithm I. Each row represents
the four genotypes of one individual.The minor alleles for the four markers are assumed
to be 2 2 2 1 respectively, and are underlined. Genotype 0 0 represents missing genotypes
in the original dataset, which is converted to 3 to indicate missing genotypes.
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genotype. Since most of the SNPs of the human genome have small MAF [The 1000
Genome Project Consortium, 2010], the improvements of this approach is substantial
compared to the binary-encoding algorithm in the last section.
Specifically, suppose we have n subjects in the data, then we need dlog2(n)e binary digits
in order to record the index of any subject. First, the number of the rare homozygous,
the heterozygous and the missing genotypes are counted. This information is used to
calculate the compressed size and determine whether Sub-algorithm II should be used
for the SNP. If Sub-algorithm II requires the smallest amount of memory, SpeedGene will
use Sub-algorithm II for the compression of the genetic data for the SNP. The indices of
the subjects with the homozygous, heterozygous and missing genotypes are transformed
into binary digits and are written into the binary file afterwards. Since the number of
subjects with each genotype varies, the counts, each requires dlog2(n)e Bits on the disk
space, are written to the file before the indices of the subjects are outputted to the file.
Thus, the storage requirement for compressing n genotypes for one marker using this
algorithm is given by
ddlog2(n)e ∗ (#Homo+ 1 + #Heter + 1 + #Missing + 1)/8e Bytes (1.2)
where #Missing denotes the number of subjects with the missing genotype, #Homo
denotes the number of subjects with the rare homozygous genotype, and #Heter denotes
the number of subjects with the heterozygous genotype.
Sub-algorithm III: Compression using binary encoding and subject indices
As we will see in the next section, Sub-algorithm II works best for SNPs with very small
MAF, but performs worse than Sub-algorithm I for more common SNPs (MAF > 0.3).
However, by combining Sub-algorithm I and II, we can create a hybrid approach that
performs better than Sub-algorithm I and II for SNPs whose MAFs are somewhere
between uncommon and very common.
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Since the heterozygous genotype is more common for genetic loci that are in the range
between uncommon and very common (0.05 ≤MAF ≤ 0.3), recording the heterozygous
genotype by the indices of subjects is not very efficient. Instead we use a binary number of
n digits to indicate the subjects with the heterozygous genotype, where n is the number
of subjects in the dataset. If subject i has the heterozygous genotype for the SNP, 1 is
put at position i instead of 0. Beside this, the indices of subjects with the missing and
homozygous minor allele genotypes are recorded in the same way as in Sub-algorithm II.
The storage requirement of the marker information for n samples using this algorithm is
given by
d((#Homo+ 1 + #Missing + 1) ∗ dlog2(n)e+ n)/8e Bytes (1.3)
where #Homo denotes the number of subjects with the rare homozygous genotype and
#Missing denotes the number of subjects with the missing genotype for the SNP.
For Sub-algorithm II and III, since the indices of the heterozygous and homozygous geno-
types are stored for each marker, this compressed data structure makes computation for
permutation methods much convenient.
1.3 Results
1.3.1 Performance Comparison of Sub-algorithms
The SpeedGene algorithm selects for each genetic locus the optimal algorithm in terms
of storage space (1.1-1.3) among the three sub-algorithms described above. To assess
the performance of the SpeedGene algorithm, we compare it with the standard LINK-
AGE/PLINK format and the PLINK/PBAT compression algorithm. The efficiency of
the SpeedGene algorithm depends on two factors, the genotype frequency of the genetic
locus and the number of subjects included in the dataset. Assuming Hardy-Weinberg
equilibrium, the first plot of Figure 1.3 gives a plot of the compression factor of the three
sub-algorithms versus different MAFs for a dataset of 1000 subjects. The second plot
shows the number of Bits needed per genotype for storing the genotype information of
1000 subjects at different MAF values. The dashed line provides the performance for the
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SpeedGene algorithm which is based on the allele frequency and formulas 1.1, 1.2 and
1.3 to select the optimal compression procedure among Sub-algorithm I-III.
As in the plot, approximately, SpeedGene always achieves a compression factor of 16
compared to the standard LINKAGE format for MAF > 0.3 for which Sub-algorithm I
is used. SpeedGene accomplishes a compression factor of 16 up to 30 compared to the
LINKAGE/PLINK format for 0.05 ≤ MAF ≤ 0.3 for which Sub-algorithm II is selected.
For rare and uncommon alleles (MAF < 0.05), a compression factor of at least 30 com-
pared to the LINKAGE format is realized. With smaller MAFs, the compression factor
increases rapidly. Equivalently, 2 Bits per genotype would be needed for MAF > 0.3,
about 1.0 to 2.0 Bits per genotype for 0.05 ≤MAF ≤ 0.3, and less than 1 Bit per genotype
is needed for MAF < 0.05.
The performance of the algorithms also depends on the number of subjects in the dataset.
Figure 1.4 shows the compression factor of the algorithms for one marker for different
number of subjects, at eight MAF levels.
Generally, the compression factor decreases slightly as the number of subjects included
increases, but is mostly constant over the range of number of subjects we have considered
for different values of MAF.
In addition to that, the plots give us similar information as the plots above. For example,
for SNP with MAF = 0.01, Sub-algorithm II is able to compress the genetic information
by a factor of at least 100, which is much better than Sub-algorithm I and III. Thus, MAF is
the most influential factor in determining which algorithm is the optimal method among
the three sub-algorithms.
1.3.2 The C++ Library Implementation
We have implemented the algorithm in a C++ library called SpeedGene. There are two
classes in the SpeedGene library. The first one is the Comp class, which is responsible for
compressing a pedigree file in the LINKAGE/PLINK format into a text file that contains
the subject information and a binary file that contains the genetic information. The binary
10
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Figure 1.3: In the left plot, the compression factors of the three sub-algorithms are plotted
against different MAF levels. In the right plot, the number of Bits needed for storing one
genotype is plotted against different MAF levels. 1000 genotypes are simulated for one
SNP at each MAF level. The space needed to store this information for one SNP in the
LINKAGE/PLINK format is 4000 Bytes. The compression factor is the number of times
by which the compressed file is smaller than the original file size (4000 Bytes).
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Figure 1.4: The compression factors of the three sub-algorithms are plotted against the
number of subjects included in one dataset at eight different MAF levels, which are 0.01,
0.02, 0.04, 0.06, 0.1, 0.25, 0.35 and 0.45. The datasets we considered include at least 100
subjects and contain only one marker with the specified MAF level.
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file is not human-readable and can only be used by the second class in our library. The
compression process requires two scans of the pedigree file to avoid storing all the marker
information before compression, which would take a great amount of memory space.
The second class is the LoadComp class. As its name suggested, it is responsible for
loading the compressed files into the memory, and for processing queries from the user.
It provides an option to load the entire pedigree file or to load a section of the file. This
partial-loading function ensures that only necessary information is loaded for the jobs
that are running in parallel, which greatly decreases the loading time. Moreover, the
public functions provided by the library allow the user to retrieve any information stored
in the original file. This C++ library makes it straightforward for users to incorporate it
into their own programs whereas other existing libraries do not offer such capability.
1.3.3 Performance
Compression rate
We evaluated the performance of the SpeedGene algorithm on two rare variants
datasets. We simulated two datasets with 1000 subjects from the Wright’s distribu-
tion [Wright, 1949], which is f(p) = cpβs−1(1 − p)βn−1eσ(1−p), where the scaled mutation
rates βs = 0.001, βn = βs/3, the selection rate σ = 12, and c is a normalizing constant.
Table 1.1 below shows the compressed file size for the simulated data. For sequencing
data, the optimal algorithm is Sub-algorithm II for most of the SNPs. Thus, SpeedGene
is able to achieve a large compression rate. In the simulated data, the compression
factor is approximately 200, which is equivalent to 0.16 Bits per genotype, whereas 2
Bits per genotype is required by PLINK or PBAT. Gzip seems to perform much better
on rare variant data than on common variant data, however, such general-purpose
software takes extra time to decompress the files before loading them into the memory.
We have also extrapolated the approximate file size if DNAzip is used [Christley et al.,
2009]. According to the paper, each SNP for one person requires slightly less than 1 Byte
per SNP for storage and it requires a reference human genome (∼ 3 Gigabytes) and a
reference SNP map ( ∼ 1.2 Gigabytes) to retrieve the entire genome data.
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Table 1.1: Compressed file sizes of the simulated datasets using PLINK, Gzip, SpeedGene
and DNAzip. Each dataset contains 1000 subjects.
#SNPs Size PLINK Gzip SpeedGene DNAzip Avg MAF
1 million 3.731 GB 238 MB 22 MB 18 MB 16 MB+ ∼ 4.2 GB 0.004944
30 million 112 GB 6.985 GB 592 MB 534 MB 310 MB + ∼ 4.2 GB 0.004228
We also applied these methods to two real datasets. One dataset contains the genotype
data from the Framingham Heart Study (FHS), which includes 6956 subjects and 340,444
SNPs. The other dataset is obtained from the COPDgene study on patients with Chronic
Obstructive Pulmonary Disease (COPD). It includes 257 subjects with 162757 SNPs over
the human genome and 77% of the SNPs in this sequencing data have a MAF ≤ 5%. The
original file size and the compressed file sizes using different compression methods are
shown in Table 1.2. For the FHS dataset, since that most of the SNPs are common, the com-
pression rate of SpeedGene is just slightly greater than that of PLINK. Gzip gives a much
lower compression ratio of 6 here, as for most common variant datasets. The COPDgene
sequence data contains mostly rare variants, but still includes some common variants, so
we observe a much higher compression rate with SpeedGene than with PLINK and Gzip.
Table 1.2: File sizes of the FHS dataset and COPDgene dataset, compressed using PLINK,
SpeedGene and Gzip.
Dataset Size PLINK Gzip SpeedGene Avg MAF
FHS 8.822 GB 564.6 MB 1.400 GB 460 MB 0.238637
COPDgene 161 MB 10.1 MB 20.5 MB 3.6 MB 0.057327
Loading time
The time for loading the compressed datasets using SpeedGene and PLINK on a 2.35GHz
AMD Opteron CPU with 128GB of RAM is shown in Table 1.3 below. The time to load
the entire file using SpeedGene is less than half of the time needed by PLINK for the
simulated datasets. If the analysis is ran in parallel, the loading time using SpeedGene
is decreased further as the number of jobs ran in parallel increases. For example, if we
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are loading 1/10 of the dataset with 30 million SNPs in each parallel job, the loading time
needed by SpeedGene is 1.8 minute.
Table 1.3: The CPU time needed for loading the two compressed files using SpeedGene
and PLINK on a 2.35GHz AMD Opteron CPU with 128GB of RAM.
Number of SNPs Loading time (SpeedGene) Loading time (PLINK)
1 million 26 sec 56 sec
30 million 11 min 29 min
1.4 Discussion
To tackle the problem of large file sizes and long loading times of genetic data, we have
developed a new compression algorithm - SpeedGene. The algorithm selects the optimal
approach among three methods in terms of the required disk space. We have shown that
the algorithm always works better than the compression algorithms provided by PBAT
and PLINK, and can reach a compression factor of sixteen up to few hundreds. Especially
for sequencing data with mostly rare variants, the algorithm is able to compress files
of hundreds of Gigabyte to hundreds of Megabytes. Similar compression rate can
be reached for the VCF files containing SNP data. In addition, the compressed data
structure requires no extra time for decompression and could reduce a large amount of
computation time for performing permutations on the genotypes.
A C++ implementation of the SpeedGene algorithm is provided and an integration in R
is ongoing, but the algorithm could be implemented easily for other data formats and
using other programming languages. The SpeedGene library utilizes the structure of
the compressed data and enables direct loading of the genotype data into the memory.
Moreover, the functions in the LoadComp class of this library allow the user to flexibly
retrieve any specified subject or genetic information from the compressed dataset. Fur-
thermore, user-friendly parallel-loading function is supported, which in result shortens
the loading time greatly when parallel jobs are dispatched in clusters.
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To fully utilize the compression algorithm, it needs to be incorporated into other analysis
software for association studies, where the genetic information can be loaded using the
library and directly sent for analysis in the software. For example, we are planning to
include this binary format as one of the standard input format in NPBAT, which is an
interactive software for the analysis of population based genetic association studies. Such
incorporation would require additional efforts, but with the gain of much more disk space
and shorter loading time, it will be beneficial in the long run.
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2.1 Introduction
Genetic association analysis has proven to be a powerful statistical tool for the iden-
tification of disease loci in the human genome [Burton et al., 2007] [McCarthy et al.,
2008] [Stranger et al., 2011]. Population-based association analysis is straightforward
and computationally fast, even at a whole-genome level. One of the main caveats of
population based association analysis, however, is that it can be susceptible to bias due
to genetic confounding, i.e. population substructure.
This issue has been the focus of statistical research for some time. In designs of unrelated
individuals, most genetic association tests take the form of a score test in which the nu-
merator sums the contributions of the study subjects to the statistics and the denominator
calculates the variance of the statistic, assuming independence of the study subjects. In
the presence of mating among relatives or population substructure, the genotypes of the
study subjects are no longer independent, leading to a potentially biased estimate for the
variance of the test statistic. This can cause the test statistic to become anti-conservative.
Genomic control approach adjusts for the bias in the variance of the test statistic by
estimating a variance inflation factor at a set of reference loci and scaling the variance of
the test statistic accordingly [Devlin and Roeder, 1999] [Reich et al., 2001b]. Recently, with
the arrival of GWAS data, Principal Component Analysis gained popularity [Price et al.,
2006] [Patterson et al., 2006]. They infer population substructure and admixture based on
the Principal Component Analysis of the variance-covariance matrix of genotyped mark-
ers [McVean, 2009] [Novembre and Stephens, 2008]. Then, the principal components are
either used to identify genetically homogenous subpopulations in the study [Luca et al.,
2008] or to adjust the association for genetic confounding [Price et al., 2006]
For the association analysis of rare variants, the application of such approaches to avoid
bias due to population substructure and admixture can be problematic. In PCA approach,
the estimation of the variance/covariance matrix can become unstable for genetic loci
with low minor allele frequencies, making the results of this approach less reliable. For
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example, the investigators usually select markers with allele frequencies greater than 10
% before applying principal component analysis [He et al., 2011] [Sladek et al., 2007].
An alternative that could be considered here is to assess population substructure for
loci with common alleles and apply the principal component results to the rare-variant
analysis, assuming that the population substructures for rare and common variants are
the same. The transferability of population substructure between common and rare
genetic loci is a hypothesis which has not been assessed thoroughly based on real data so
far. The general applicability of this concept seems to be problematic in light of the age
of the different variant types, i.e. common variants are genetically much older than rare
variants [Mathieson and McVean, 2012]. Although rare variant approaches rely mostly
on permutation tests for the assessment of the significance, the concept of genomic
control generally can be modified and applied to rare variant analysis. However, it can
give a reduced power and cannot be utilized to identify homogeneous subpopulations.
Here, we proposed a simple, computationally fast approach that allows the identification
of genetic outliers to obtain a genetically homogeneous subpopulation in studies with se-
quence data, minimizing the impact of population substructure on rare variants analysis.
The approach is able to utilize the information on all available genetic loci and does not
require the selection of a subset of markers that are not in linkage disequilibrium (LD).
The test statistic is computed for each individual based on all the rare variant information
available. The power and the type I error of the approach are examined in simulation
studies and by the applications to the HapMap 3 and the 1000 Genome Project data. We
compare the performance of our approach with the outlier detection algorithm based on
PCA.
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2.2 Material and Methods
2.2.1 Introducing test statistics T1 and T2
Suppose in a genetic association study of unrelated individuals, genotype data is avail-
able at m bi-allelic loci for all the study subjects. We denote the number of the minor
alleles at the ith marker locus by Xi for one subject. We define the genetic residual by
∆Xi = Xi−E(Xi) whereE(Xi) is the expected number of the minor alleles at the ith locus
in the study population. The genetic residual can be considered as the genetic deviation
of the subject at ith locus from the study population. We define two genome-wide scores
that measure the distance between a particular individual and the population across the
genome. The scores are given by
S1 =
m∑
i=1
∆Xi =
m∑
i=1
(Xi − E(Xi))
and
S2 =
m∑
i=1
|∆Xi| =
m∑
i=1
|Xi − E(Xi)|.
Based on the scores, we can construct the score tests T1 and T2 which are given by
T1 = R
2
1 =
(S1 − E(S1))2
V ar(S1)
and
T2 = R
2
2 =
(S2 − E(S2))2
V ar(S2)
.
The first score aggregates the residuals over all the marker loci for one subject. If, for the
study population and the population where the outliers are from, there is preferentially
a one-direction difference in the MAF, i.e. most of the markers have smaller MAF
in one population than in the other population, then the test score S1 will be more
powerful in detecting the population outliers. This situation can occur due to the founder
effects in one subpopulation [Roy-Gagnon et al., 2011] [Reich et al., 2001a], long-range
haplotypes [Price et al., 2008], etc. However, if the differences in minor allele frequencies
between two subpopulations do not follow this patterns, test statistic S2 is generally
better suited to identify genetically different subjects. In Appendix A.3, we provide the
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theoretically justification for that. We will further outline these features of the score
statistics S1 and S2 in the simulation section of this paper.
Under the assumption of Hardy-Weinberg equilibrium, the expected marker score can be
calculated based on the minor allele frequency, i.e. E(Xi) = 2pi, where pi is the true minor
allele frequency at ith marker locus. For any real dataset, we can estimate the allele fre-
quency pi by the observed frequency of the minor allele in the actual data. Alternatively,
the allele frequencies can be obtained from the corresponding reference populations. As-
suming the absence of LD between the loci, the mean and variance of S1 and S2 can be
derived analytically based on the allele frequencies, as shown in Appendix A.1. Then the
test statistics are given by:
T1 =
[
m∑
i=1
(Xi − 2pi])2
m∑
i=1
(2pi(1− pi))
(2.1)
T2 =
[
m∑
i=1
|Xi − E(Xi)| − (2pi(1− pi))]2
m∑
i=1
(2pi(1− pi)(1− 8pi(1− pi)3))
(2.2)
Then, under the null hypothesis of no population substructure, both test statistics T1 and
T2 follow a χ2 distribution with one degree of freedom.
2.2.2 Adjusting T1 and T2 in the presence of LD
For sequence data, the LD assumption may not always be reasonable unless only a subset
of loci that are not in LD is selected. In the presence of LD, both standardized scores have
to be adjusted accordingly. Since the variances of S1 and S2 do not depend on the actual
genotype of the study subject and are constant across the subjects, ideally, we would need
to adjust T1 by
V ar(
m∑
i=1
∆Xi)
m∑
i=1
V ar(∆Xi)
21
However, since the calculation of the correlations of the residuals across the genome re-
quires a great amount of computation time, a genomic inflation factor for each test statistic
can be estimated based on the distribution of the test statistic across the study subjects.
For test statistic T1, we estimate the genomic inflation λ1 by
λˆ1 =
Median of T1 across all subjects
0.455
(2.3)
where 0.455 is the 50th percentile of a χ2(1) distribution. Similarly for T2, we estimate the
genomic inflation factor λ2 by
λˆ2 =
Median of T2 across all subjects
0.455
(2.4)
In the presence of LD, we can adjust T1 using the subject inflation factor λ1 by
1
λ1
T1 =
(S1 − E(S1))2
λ1
m∑
i=1
V ar(∆Xi)
∼ χ2(1) (2.5)
The adjusted test statistic T2 is derived in the same way. Under the null-hypothesis that
the subject is from the study population, the test statistics T1 and T2 have an asymptotic
χ2-distribution with one degree of freedom.
2.2.3 The optimal test and its asymptotic distribution
Since, prior to the calculation of the test statistic, we do not have any knowledge whether
test statistic T1 or T2 is more suitable for the analyzed study subject, we define the genome-
wide test statistic to detect genetic outliers in rare-variant data as:
Topt = max(T1, T2) (2.6)
We already know that assuming no LD between the markers, and under the null
hypothesis that the subject under study is from the given population, the standardized
test statistics T1 and T2 follow a χ2(1) distribution asymptotically. To derive the asymptotic
distribution of Topt, we need to incorporate the correlation between the test statistics T1
and T2. In the absence of LD between the genetic loci, an estimator of the correlation
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between R1 and R2 based on the allele frequencies of the loci can be easily derived (Ap-
pendix A.2). As an alternative approach or in the presence of LD, the correlation between
R1 and R2 can also be estimated by the empirical correlation between the statistics R1
and R2 in the study (Appendix A.2). Given the estimate for the correlation/covariance of
R1 and R2, the asymptotic distribution of Topt can be obtained under the null hypothesis,
by simulating from a bivariate normal distribution with the estimated correlation. In
Appendix A.2, we outline the derivation of the asymptotic distribution for Topt in more
details.
2.3 Results
We examined the performance of the test statistic Topt by its applications to the third
release of HapMap 3 data and the third version of 1000 Genome Project data, and in
simulation studies with sequencing and GWAS data. In all applications and simulation
scenarios, the approach was compared to the outlier detection algorithm based on
PCA. For this comparison, we selected the smartpca implementation of PCA in the
EIGENSTRAT package [Price et al., 2006].
2.3.1 Applications to HapMap 3 data
HapMap 3 [Altshuler et al., 2010] provides a unique framework to validate our ap-
proach based on real data. The genotype data were generated from 1,397 samples in
11 populations, obtained with the Affymetrix Human SNP array 6.0 and the Illumina
Human1M-single Beadchip. The consensus number of polymorphic SNPs in the 11
populations is 1,457,897. We selected the US Utah residents with ancestry from northern
and western Europe (CEU), Han Chinese in Beijing (CHB), and the Yoruba in Ibadan,
Nigeria (YRI) as the populations for the construction of our ”toy”-data sets. Since these
three populations can be considered to be genetically homogeneous (Supplementary
information of [Altshuler et al., 2010]), they are an ideal validation tool for methodology
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to detect population substructure. The general idea is to create data sets that consist of
one population, and include one additional subject that is not part of the population. The
following combinations/data sets can thereby be constructed:
1. 1 CEU subject + all YRI subjects (112 such datasets)
2. 1 YRI subject + all CEU subjects (147 such datasets)
3. 1 CHB subject + all YRI subjects (137 such datasets)
4. 1 YRI subject + all CHB subjects (147 such datasets)
5. 1 CEU subject + all CHB subjects (112 such datasets)
6. 1 CHB subject + all CEU subjects (137 such datasets)
Both methods, the proposed test statistic and the outlier detection method based on PCA,
were applied to each dataset. For each subset, several QC steps were implemented to
ensure that the remaining autosomal SNPs have a call rate > 98%, are in Hardy-Weinberg
equilibrium (HWE-test p-value > 0.000001), and the subjects are unrelated. Before
applying the PCA approach, SNPs in the long-range LD regions [Price et al., 2008] were
also removed and the SNP-set was pruned to have pairwise r2 < 0.1 in every 200 SNPs
window with a step size of 20 SNPs using PLINK [Purcell et al., 2007].
In each application/replicate, we assess whether the two methods correctly identify the
subject that is not part of the population as an outlier. A subject is rejected as an outlier if
its test statistic Topt is greater than the value corresponding to the significance level 0.05/n
where n is the number of subjects in the dataset. In the smartpca algorithm provided in
EIGENSTRAT, we used the default values recommended in the package, i.e. 10 for the
number of principal components used for determining outliers, and 6 for the number
of standard deviations of which the subject must deviate in any of the top 10 PCs to be
removed as an outlier. We also used the default maximum number of outlier removal
iterations, which is 5 in the process.
The number of false positive findings is recorded as well. Based on these results, we
estimated the power, the type I error and the family-wise error rate (FWER) of both
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approaches for all 6 scenarios shown above. The type I error is the average percentage of
incorrectly rejected subjects among the combined datasets for each scenario. The FWER
is the percentage of times that there is at least one incorrectly rejected subjects in the
112 datasets. The methods were applied first to all the common SNPs, which, for PCA,
are SNPs with minor allele frequency > 10% and which, for our approach, are all the
available SNPs, including rare SNPs and SNPs in the long-range LD-regions ( [Price et al.,
2008]). Then, we applied the two approaches to the rare SNPs (minor allele frequency <
5%). The results are shown in Table 2.1.
Table 2.1: The estimated Family-wise error rate (FWER), the average type I error (TI) and
the power of Topt and the outlier detection process based on PCA when they were applied
to the combined HapMap 3 datasets
Pop CEU YRI YRI CHB CEU CHB
Estimates Outlier YRI CEU CHB YRI CHB CEU
FWER 1.00 1.00 1.00 0.00 1.00 0.00
PCA (MAF > 10%) TI 0.0178 0.107 0.106 0.00 0.0177 0.00
POWER 1.00 1.00 1.00 1.00 1.00 1.00
FWER 1.00 1.00 1.00 1.00 1.00 1.00
PCA (MAF < 5%) TI 0.0739 0.161 0.0752 0.158 0.0734 0.0736
POWER 1.00 1.00 1.00 1.00 1.00 1.00
FWER 0.00 0.00 0.00 0.00 0.255 0.00
Topt (MAF < 5%) TI 0.00 0.00 0.00 0.00 0.00226 0.00
POWER 1.00 1.00 1.00 1.00 1.00 1.00
FWER 0.00 0.00 0.00 0.00 1.00 0.00
Topt (all SNPs) TI 0.00 0.00 0.00 0.00 0.00885 0.00
POWER 1.00 1.00 1.00 1.00 1.00 1.00
For both common and rare variants, the results show that the outlier detection algorithm
implemented in EIGENSTRAT and our approach, Topt, are able to detect all the outliers,
i.e. empirical power estimates of 100%, in all of the combined datasets. However, PCA is
not able to maintain the type I error and the family-wise error rate (FWER). For example,
the average type I error of PCA can reach levels of up to 0.1 in two of the six cases and the
FWER is always 1. Our method maintains the type I error in almost all the cases, and for
both rare and common variants. The exception may be due to one labelled CEU subject
that is genetically far from the CEU population, so that it is often seen as an outlier of
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the CEU population. Since the exclusion of study subjects with false-positive test results
will reduce the statistical power of the sequence analysis or the GWAS, a large false-
positive rate is not a desirable feature of a method for the detection of population outliers.
It may be argued that the criteria of detecting outliers we used in PCA may not be
optimal to reject the outliers in these cases. However, we note that 6 standard deviations
is commonly used in detecting outliers in the QC step and it is already a stringent criteria.
The point is that the outlier detection algorithm based on PCA is not a statistical test so
that it is likely to reject subjects incorrectly.
2.3.2 Applications to 1000 Genome Project data
Similarly, we applied the novel test to the 3rd release of the variant call set based on
both low coverage and exome whole genome sequence data from the 1000 Genome
Project [The 1000 Genome Project Consortium, 2010]. The release contains the genotype
calls of 1,092 samples from 14 different populations. We combined three pairs of popu-
lations as for the HapMap 3 data to investigate the power, type I error, and FWER of the
test. The three pairs are Han Chinese in Beijing, China (CHB) and Japanese in Tokyo,
Japan (JPT), Tuscany in Italy (TSI) and Finnish from Finland (FIN), Yoruba in Ibadan,
Nigeria (YRI) and Luhya in Webuye, Kenya (LWK). Each pair of the populations are
genetically closer comparing to the pair of populations studied in the HapMap 3 data.
We focused only on the SNPs calls, thus any information on the short Indels or large
deletions are ignored. With similar quality control process as for the HapMap 3 data, we
are left with approximately 11M SNVs for the combined datasets CHB and JPT, and FIN
and TSI, and with approximately 19M SNVs for the combined datasets LWK and YRI.
To apply PCA, the three combined datasets, CHB and JPT, FIN and TSI, and LWK and
YRI, have been pruned to include SNPs with MAF > 10% and with pairwise r2 < 0.05
in each 50 SNPs window with a step size of 5 SNPs. This pruned dataset for CHB and
JPT includes about 92K SNPs, similar for FIN and TSI. The pruned dataset for LWK and
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YRI includes about 150K SNPs. To compare with the new test, PCA was also applied to
the SNVs with MAF ≤ 5% without any LD pruning. There are about 6M-7M such SNVs
for the combined datasets of CHB and JPT, and of FIN and TSI, and there are about 13M
such SNVs (MAF ≤ 5%) for the combined datasets of LWK and YRI.
The power, type I error and FWER estimates are shown in Table 2.2. In each case, there
is only one outlier included in each dataset here. The power, type I error and FWER
are averaged across the datasets with different outliers from the other population. The
table shows that PCA cannot detect the outlier using the pruned SNP set with MAF
> 10% due to the small number of SNPs included in the pruned data and the closeness
of the two populations. PCA has a good power to detect the outlier using SNPs with
MAF ≤ 5%. However, the outlier detection algorithm based on PCA does not control
for the type I error or the FWER, which would result in the unnecessary removal of
samples. The new statistic Topt has a good power to detect the outliers, especially for
the more distant pairs, TSI and FIN, and LWK and YRI. The type I error and the FWER
are mostly controlled well. Note that there are a few surprises here. one is that the
asymmetry in the power for the dataset of LWK with one YRI sample as the outlier and
the dataset of YRI with one LWK as the outlier. This can be explained by the larger
genetic variation of the LWK population than the YRI population. However, we observe
that, using SNPs with MAF ≤ 5%, we have a much better power to detect the YRI
outliers included in the LWK samples. This may due to the fact that a lot of variants
that contribute in distinguishing the two populations are rare since the separation of
the two populations are relatively recent. This is also true for the other combined datasets.
We further investigated the performance of the test by introducing more than one
outliers into the dataset. The results are shown in Table 2.3 and Table 2.4. We randomly
selected 5 or 10 outliers from the outlier population and they were combined with the
corresponding study population to assess the performance of the approaches. There are
1000 such randomly generated datasets in all the scenarios except for evaluating the
performance of PCA on SNVs with MAF ≤ 5%, where 500 datasets were generated.
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Table 2.2: The estimated Family-wise error rate (FWER), the average type I error (TI) and
the power of Topt and the outlier detection process based on PCA when they were applied
to the combined 1000 genome datasets
Pop CHB JPT TSI FIN LWK YRI
Estimates Outlier JPT CHB FIN TSI YRI LWK
FWER 0.00 0.00 0.00 0.00 1.00 0.00
PCA (MAF > 10%) TI 0.00 0.00 0.00 0.00 0.0125 0.00
POWER 0.00 0.00 0.151 0.00 0.0349 0.00
FWER 1.00 1.00 0.151 0.990 1.00 1.00
PCA (MAF < 5%) TI 0.144 0.0935 0.00351 0.0765 0.0489 0.0234
POWER 0.843 0.443 0.957 0.888 0.570 1.00
FWER 0.00 1.00 0.00 0.00 0.00 0.00
Topt (MAF < 5%) TI 0.00 0.0415 0.00 0.00 0.00 0.00
POWER 0.146 0.495 1.00 1.00 0.988 1.00
FWER 0.0225 1.00 0.882 0.00 0.00 0.00
Topt (all SNPs) TI 0.00 0.0365 0.000869 0.00 0.00 0.00
POWER 0.0562 0.0928 0.720 0.969 0.00 0.861
We observe that even with more outliers included in the dataset, our method performs
generally better than PCA, especially in the combined datasets of TSI and FIN, and LWK
and YRI. PCA continues to have a large type I error rate and FWER in all the scenarios.
We also observe again that the performance of the novel test is much better using the
SNPs with MAF ≤ 5%, than using all the SNPs.
Note that as the proportion of outliers included in the dataset continues to increase,
the power of our test decreases. This is because that as more outliers are included in
the dataset, the estimated MAF and the expected number of alleles obtained from the
data are biased toward the outlier population. Then the test statistics would be biased
and would not follow the same distribution as under the null hypothesis. Thus, the
novel method is mainly used to detect a relatively small set of outliers. The effect of the
proportion of the outliers included in the dataset on the test statistics also depends on
the genetic distance of the populations.
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Table 2.3: The estimated Family-wise error rate (FWER), the average type I error (TI) and
the power of Topt and the outlier detection process based on PCA when they were applied
to the combined 1000 genome datasets with 5 outliers included in each scenario
Pop CHB JPT TSI FIN LWK YRI
Estimates Outlier JPT CHB FIN TSI YRI LWK
FWER 0.00 0.0540 0.00 0.00 1.00 0.00
PCA (MAF > 10%) TI 0.00 0.000607 0.00 0.00 0.0276 0.00
POWER 0.01 0.00 0.00 0.00 0.00 0.00
FWER 1.00 0.984 0.900 0.820 0.982 0.926
PCA (MAF < 5%) TI 0.125 0.0939 0.0509 0.0271 0.0531 0.0219
POWER 0.685 0.248 0.166 0.391 0.002 0.919
FWER 0.00 1.00 0.00 0.00 0.00 0.00
Topt (MAF < 5%) TI 0.00 0.0119 0.00 0.00 0.00 0.00
POWER 0.0728 0.301 1.00 1.00 0.988 1.00
FWER 0.001 1.00 1.00 0.00 0.00 0.00
Topt (all SNPs) TI 0.0000103 0.0251 0.0102 0.00 0.00 0.00
POWER 0.0552 0.0628 0.727 0.480 0.00 0.485
Table 2.4: The estimated Family-wise error rate (FWER), the average type I error (TI) and
the power of Topt and the outlier detection process based on PCA when they were applied
to the combined 1000 genome datasets with 10 outliers included in each scenario
Pop CHB JPT TSI FIN LWK YRI
Estimates Outlier JPT CHB FIN TSI YRI LWK
FWER 0.00 0.166 0.00 0.00 0.746 0.00
PCA (MAF > 10%) TI 0.00 0.0168 0.00 0.00 0.0158 0.00
POWER 0.00 0.00 0.00 0.00 0.00 0.0024
FWER 1.00 0.810 0.966 0.676 0.978 0.985
PCA (MAF < 5%) TI 0.100 0.0723 0.0230 0.0151 0.0500 0.0352
POWER 0.479 0.127 0.854 0.258 0.0618 0.885
FWER 0.00 0.0119 0.00 0.00 0.00 0.00
Topt (MAF < 5%) TI 0.00 0.000134 0.00 0.00 0.00 0.00
POWER 0.0286 0.204 0.982 0.0846 0.633 1.00
FWER 0.00 1.00 0.982 0.00 0.00 0.00
Topt (all SNPs) TI 0.00 0.0207 0.0100 0.00 0.00 0.00
POWER 0.0410 0.0421 0.459 0.0557 0.00 0.124
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2.3.3 Simulations
In addition to the analyses on the HapMap 3 and 1000 Genome Project data, we per-
formed simulation studies under the alternative hypothesis to examine whether the
proposed test Topt has sufficient power to detect outliers. We assessed the power of the ap-
proach to detect genetic outliers based on both rare variants and common variants. In our
simulations, the Balding-Nichols model [Balding and Nichols, 1995] was applied to gen-
erate the allele frequencies of the two sub-populations: pi1, pi2 ∼ Beta(1−FF pi, 1−FF (1− pi)),
where pi1, pi2 are the allele frequencies of marker locus i for the two sub-populations; F
is the Fst, the genetic distance between the two sub-populations [Holsinger and Weir,
2009] and the parameter pi is the background allele frequency for marker locus i. In
the simulation studies for the rare variants, the background allele frequencies pi were
generated from the Wright’s distribution [Wright, 1949] using Metropolis-Hastings
algorithm: f(p) = cpβs−1(1 − p)βn−1eσ(1−p), where the scaled mutation rates are elected
to be βs = 0.001, βn = βs/3, the selection rate σ = 12, and c is a normalizing constant.
The Wright’s distribution is expected to simulate the MAF spectra of the human genome
under week purifying selection, where most of the MAFs generated are smaller than
5% [Wright, 1949]. To generate common variant data, we generated the background
allele frequencies pi from the Uniform distribution Unif(0, 0.5).
Under the models defined by these parameters, we draw two sets of allele frequencies
for the two sub-populations in each trial. In analogy to the HapMap analysis, one study
subject was generated from the first sub-population, while the remaining study subjects
in the dataset were generated from the second sub-population.
Power
Based on 1000 replicates, we estimated the power of the test under each scenario for
both common variant and rare variant data. The power is estimated by the percentage
of trials in that the outlier is detected using Topt, where the test statistic is adjusted for
multiple comparisons, i.e. study subjects, using the Bonferroni correction. The results
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are shown in Table 2.5 and Table 2.6. Table 2.5 suggest that the test Topt has sufficient
power in most of the scenarios for rare variant data, especially for datasets with one
million markers. This is expected since, as the number of markers increases, there is
more information about the genetic structure of the population, and it is easier for the
test to capture any small difference between the outlier and the rest of the subjects in the
dataset. The genetic distance of the two sub-populations, Fst, is varied over a wide range,
and we observe a decrease in the power of the test as Fst decreases, as we would expect.
Also, we find that the percentage of markers with smaller MAF in the first population
than in the second population also influences the power of the test, especially when the
two populations are genetically close to each other. However, after assessing the power
for the percentage between 50% and 75% (data not shown), we found that, as long as the
percentage is above 50%, i.e. there is LD in the sample, we have a good power to detect
the outlier under the scenarios we considered.
For common variant data, the power of the test becomes very small when the percentage
of markers with smaller MAF in one population than in the other population is approx-
imately 50%, even for large number of SNPs. However, as the percentage increases. the
power increases rapidly. This is due to the small power offered by the score S2 since S1
does not have much power under the 50% scenario. It is important to note that, in a real
data set, we would not expect the percentage to be exactly 50% if all available genetic loci
are included in the calculation of the test statistic and there is LD between the loci.
We also compared our approach and the PCA approach for rare variant data, as shown
in Table 2.7. We observe that both the proposed test statistic and PCA have sufficient
statistical power in most scenarios. However, when there is a systematic difference in
allele frequencies between the two populations, the PCA approach does not perform
well. In practice, this effect on PCA can be minimized by the removal of long-range
LD-regions and LD-pruning for common variant analysis, but would be unavoidable for
sequence data.
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Table 2.5: Power of Topt for rare variant data
Fst Perc 500*10k 1000*10k 500*100k 1000*100k 500*1M 1000*1M
0.20 100% 0.898 0.905 0.991 0.990 0.998 1.000
75% 0.879 0.867 0.990 0.995 0.997 0.998
50% 0.914 0.870 0.988 0.986 1.000 1.000
0.15 100% 0.904 0.900 0.983 0.987 1.000 0.998
75% 0.854 0.857 0.989 0.954 0.999 0.998
50% 0.880 0.856 0.987 0.987 1.000 1.000
0.10 100% 0.894 0.887 0.988 0.984 1.000 1.000
75% 0.859 0.833 0.981 0.982 0.998 0.999
50% 0.835 0.796 0.981 0.986 1.000 0.999
0.05 100% 0.878 0.875 0.980 0.983 0.997 0.996
75% 0.807 0.777 0.973 0.974 0.998 0.997
50% 0.388 0.354 0.967 0.970 0.998 0.996
0.01 100% 0.828 0.825 0.973 0.979 0.999 0.999
75% 0.453 0.401 0.968 0.963 0.995 0.997
50% 0.003 0.006 0.031 0.025 0.863 0.839
0.005 100% 0.757 0.748 0.987 0.977 0.997 0.999
75% 0.183 0.119 0.947 0.950 0.993 0.997
50% 0.005 0.003 0.002 0.004 0.149 0.118
The number of subjects in the datasets is either 500 or 1000. The number of SNPs
included is 10,000, 100,000, or 1 million. The first column refers to the genetic distance of
the two sup-populations in the dataset. The second column shows the percentage of the
markers with a smaller MAF in the first sub-population than in the second
sub-population.
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Table 2.6: Power of Topt for common variant data
Fst Perc 500*10k 1000*10k 500*100k 1000*100k 500*1M 1000*1M
0.20 100% 1.000 1.000 1.000 1.000 1.000 1.000
75% 1.000 1.000 1.000 1.000 1.000 1.000
50% 0.003 0.004 0.001 0.002 0.003 0.006
0.15 100% 1.000 1.000 1.000 1.000 1.000 1.000
75% 1.000 1.000 1.000 1.000 1.000 1.000
50% 0.001 0.002 0.002 0.001 0.001 0.001
0.10 100% 1.000 1.000 1.000 1.000 1.000 1.000
75% 1.000 1.000 1.000 1.000 1.000 1.000
50% 0.001 0.000 0.003 0.001 0.002 0.001
0.05 100% 1.000 1.000 1.000 1.000 1.000 1.000
75% 1.000 1.000 1.000 1.000 1.000 1.000
50% 0.003 0.000 0.000 0.000 0.000 0.000
0.01 100% 1.000 1.000 1.000 1.000 1.000 1.000
75% 0.999 0.999 1.000 1.000 1.000 1.000
50% 0.056 0.030 0.000 0.000 0.000 0.000
0.005 100% 1.000 1.000 1.000 1.000 1.000 1.000
75% 0.901 0.880 1.000 1.000 1.000 1.000
50% 0.009 0.011 0.034 0.017 0.001 0.000
The ancestral MAFs are generated from Unif(0, 0.5) for the datasets. The number of
subjects in the datasets is either 500 or 1000. The number of SNPs included is 10,000,
100,000, or 1 million. The first column refers to the genetic distance of the two
sup-populations in the dataset. The second column shows the percentage of the markers
with a smaller MAF in the first sub-population than in the second sub-population.
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Table 2.7: Power of Topt and the outlier detection process based on PCA for rare variant
data.
Fst Perc 500 subjects x 10 k 1000 subjects x 10 k
PCA Topt PCA Topt
0.2 100% 0.05 0.93 0.00 0.90
75% 0.90 0.84 0.90 0.87
50% 0.93 0.87 0.93 0.87
0.15 100% 0.06 0.92 0.05 0.87
75% 0.86 0.88 0.90 0.79
50% 0.94 0.90 0.96 0.92
0.10 100% 0.03 0.96 0.05 0.88
75% 0.65 0.84 0.67 0.81
50% 0.92 0.80 0.94 0.86
0.05 100% 0.03 0.89 0.02 0.88
75% 0.20 0.80 0.38 0.77
50% 0.90 0.33 0.94 0.28
0.01 100% 0.04 0.84 0.04 0.78
75% 0.05 0.37 0.04 0.37
50% 0.37 0.00 0.48 0.00
0.005 100% 0.00 0.73 0.00 0.73
75% 0.03 0.15 0.07 0.12
50% 0.10 0.00 0.19 0.01
The ancestral MAFs are generated from the Wrights distribution for the datasets. The
number of SNPs included is 10,000.
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Type I Error
Using the same set of simulated data, the type I error is estimated as the average
percentage of subjects who are incorrectly rejected. The results for the rare variants are
shown in Table 2.8. In the scenarios considered, the nominal type I error is 0.05/n, where
n is the number of subjects included in the dataset, to maintain the FWER at 0.05 level.
Thus the nominal type I error is 0.0001 for 500 subjects and 0.00005 for 1000 subjects.
From the results, we observe that for rare SNPs, the type I error for 10000 SNPs is inflated,
but for datasets with a large number of SNPs, the type I error rate is acceptable. For
common variants, the type I error is well-maintained in all the scenarios (data not shown).
Table 2.8: Type I error of Topt for rare variant data
Fst Perc 500*10k 1000*10k 500*100k 1000*100k 500*1M 1000*1M
0.20 100% 0.00190 0.00235 0.000611 0.000267 0.0000842 0.0000390
75% 0.00247 0.00206 0.000291 0.000167 0.0000922 0.0000551
50% 0.00161 0.00255 0.000329 0.000410 0.0000782 0.0000240
0.15 100% 0.00189 0.00155 0.000517 0.000625 0.0000581 0.0000270
75% 0.00229 0.00257 0.000679 0.000381 0.000108 0.0000561
50% 0.00273 0.00241 0.000361 0.000128 0.0000802 0.0000300
0.10 100% 0.00211 0.00265 0.000475 0.000332 0.0000782 0.0000350
75% 0.00221 0.00239 0.000293 0.000150 0.000164 0.0000440
50% 0.00362 0.00211 0.000792 0.000289 0.000190 0.0000430
0.05 100% 0.00274 0.00190 0.000569 0.000261 0.0000902 0.000181
75% 0.00337 0.00296 0.000754 0.000290 0.000118 0.000182
50% 0.00287 0.00288 0.000443 0.000432 0.000132 0.0000741
0.01 100% 0.00326 0.00228 0.000523 0.000420 0.000122 0.0000821
75% 0.00296 0.00272 0.000361 0.000673 0.000152 0.0000881
50% 0.00370 0.00359 0.000627 0.000186 0.000140 0.0000671
0.005 100% 0.00226 0.00211 0.000387 0.000242 0.000325 0.0000551
75% 0.00322 0.00261 0.000291 0.000124 0.000204 0.0000801
50% 0.00350 0.00367 0.000409 0.000713 0.000184 0.0000631
The ancestral MAFs are generated from the Wrights distribution for the datasets. The
number of subjects in the datasets is either 500 or 1000. The number of SNPs included is
10,000, 100,000, or 1 million. The first column refers to the genetic distance of the two
sup-populations in the dataset. The second column shows the percentage of the markers
with a smaller MAF in the first sub-population than in the second sub-population.
35
The same pattern is observed for the FWER as for the type I error rate. FWER is estimated
as the number of trials among 1000 trials such that at least one subject is wrongly
rejected. For common variant data, the FWER is well below 0.05 for all the scenarios. For
rare variant data, we do see an inflation in the FWER as the type I error rate when the
number of SNPs included in the dataset is small. However, in real data set, e.g. whole
exome sequencing, GWAS, etc., we expect that a sufficient number of loci is available to
guarantee that the FWER is maintained.
As a last comparison, we assessed the performance of both approaches under the
null hypothesis. As shown in Table 2.9, for rare variants generated from the Wright’s
distribution, PCA has much larger FWER compared to Topt. In almost all the trails, PCA
rejected at least one subject incorrectly, whereas Topt has been shown above that the
FWER is acceptable when the number of SNPs included is sufficiently large. For common
variants, the FWER of both approaches is well-maintained with 500 or 1000 subjects
included in the datasets.
Table 2.9: FWER of Topt and the outlier detection process based on PCA for rare variant
data
FWER 500 x 10 k 1000 x 10 k 500 x 100 k 1000 x 100 k
Dist PCA Topt PCA Topt PCA Topt PCA Topt
Wright 0.912 0.106 0.978 0.123 0.928 0.066 0.989 0.060
2.4 Discussion
The large-scale applications of next-generation sequencing technology to association
studies require the development of robust and powerful analysis approaches. While
substantial progress has been made in terms of the development of association tests
for rare variants [Li and Leal, 2008] [Madsen and Browning, 2009] [Ionita-Laza et al.,
2011] [Mukhopadhyay et al., 2010] [Neale et al., 2011], there is yet no standard statistical
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approach that addresses the issues of population-substructure for sequence data.
Recently, a permutation procedure is proposed by Epstein et al [Epstein et al., 2012] to
address the problem in association tests of rare variations. It is a nice approach that
benefits the rare-variant association tests that cannot correct for confounding. However,
it is subject to the same problem as other rare-variant association tests that may be
adjusted for ancestry due the fact that the ancestry covariates obtained using PCA may
not be accurate as the type I error of the association tests after adjusting for ancestry using
PCA has been shown to be still inflated under certain scenarios [Mathieson and McVean,
2012]. Here, we try to approach the problem from a different direction, by obtaining a
homogeneous sub-population to remove confounding and avoid the hassle of estimating
the ancestry covariates for rare variants. In this communication, we proposed a method
that can detect study subject that introduce population substructure in the sample,
potentially confounding the association analysis. Our approach is computationally fast
and simple, i.e. the method is computed based on all available genetic loci, making
LD estimation and pruning unnecessary. The approach works well for both rare and
common variants. We illustrated this by the applications to the HapMap 3 and the 1000
Genome Project data, and in our simulation studies.
While these are the advantages over the standard PCA analysis, our approach does
not assess the pairwise similarity of study subjects, e.g. principal component plots.
This restricts our approach to the role of an outlier detection tool. Unlike principal
components, an integration of the test statistic into a regression model as an adjustment
for population substructure is problematic for this reason. Additional research on this
topic is required.
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3.1 Introduction
In the search for disease susceptibility loci (DSLs), genome-wide association studies
(GWAS) have been a successful instrument for the identification of replicable genetic
associations [Manolio et al., 2008,Hardy and Singleton, 2009]. For most complex diseases
and phenotypes, they discovered numerous genetic associations that can be validated
in independent populations, although the genetic effect sizes of the loci are relatively
small. Despite of the large number of detected loci, GWAS association signals are only
able to explain a small fraction of the overall predicted heritability [Visscher et al.,
2008], i.e. the phenomenon of ”missing heritability”. One possible explanation for
this phenomenon is ”synthetic associations” [Dickson et al., 2010]. Simulation studies,
theoretical considerations and empirical evidence [Nejentsev et al., 2009, Adzhubei et al.,
2010] , suggest that genetic associations, as they are detected by GWAS, can be caused by
multiple rare variants (RVs). Because common variants are poor proxies for RVs or are
not in linkage disequilibrium with rare disease-causing variants, it is difficult to identify
or characterize rare DSLs in GWAS data.
Another plausible explanation for the phenomenon of ”missing heritability” is insuffi-
cient statistical power due to the multiple-testing problem. In a GWAS, one million and
more genetic loci are tested individually for association with the target phenotype, and
the test results have to be adjusted for multiple comparisons, leading to extremely small
p-value thresholds for overall statistical significance. The standard approach has been
aimed to increase the sample size of GWAS as much as possible. For example, several
meta-analyses of GWASs [Allen et al., 2010] have contained the data of more than 100,000
study subjects. However, such large sample sizes hold the danger of increased study
heterogeneity and do not necessarily lead to increased statistical power.
The fundamental issue with the standard analysis approach to GWAS (single locus
association testing and adjustment for multiple comparisons), is that an increase in
genomic resolution, i.e. adding more and more genetic loci to the analysis, does not
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increase the probability to detect DSLs, but diminishes the statistical power of the
approach. To address this issue, multi-loci tests have been suggested. For example,
gene-based analysis has been advocated [Neale and Sham, 2004] to complement allelic
association analysis of single loci. This is motivated by the idea that causal variants
for one disease tend to reside in proximity to each other and variants in adjacent
regulatory regions are more likely to have functional relevance [Huang et al., 2011].
PLINK [Purcell et al., 2007] provides ”set-based” tests using the average SNP statistic
across the set of SNPs to realize this idea. Moreover, other tests such as the minSNP
test, the Bayesian imputation-based association mapping (BIMBAM) test [Servin and
Stephens, 2007], the versatile gene-based test (VEGAS) test [Liu et al., 2010] and the
LASSO regression method for GWAS [Wu et al., 2009] has been proposed. Recently,
the Gene-wide Significance (GWiS) test [Huang et al., 2011] has also been developed by
Huang et al which could also be used to estimate the number of independent effects
within a gene. For next-generation sequencing data, methods aggregate over a set of rare
variants to search for associated genomic regions with the disease status are shown to
be more powerful, such as the cohort allelic sums test (CAST) [Morgenthaler and Thilly,
2007], the Combined Multivariate and Collapsing (CMC) method [Li and Leal, 2008],
the weighted sum statistic by Madsen and Browning [Madsen and Browning, 2009], the
kernal-based adaptive clustering (KBAC) test [Liu and Leal, 2010], the sequence kernel
association test (SKAT) [Wu et al., 2011], replication-based test (RBT) [Ionita-Laza et al.,
2011], etc. There are several advantages of such gene-based tests over single loci tests.
First, collapsing the small effects across the variants within a gene could give larger effect
size to detect the association. Secondly, due to the smaller number of genes to be tested,
the multiple testing problem is reduced. Moreover, the associations of genes across
different populations can be directly compared even though there could be different
linkage disequilibrium patterns within the genes across the populations [Huang et al.,
2011].
However, all of the approaches can handle only a very limited number of genetic loci,
i.e. typically less than 100. None of them is able to incorporate the information about the
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physical location of the loci and their clustering. In this paper, we are proposing a novel
approach that can test a large genomic region for association with the target phenotype
by taking into account the physical location of the variants that show evidence for
association and their physical clustering. The genomic region could refer to one gene,
a specified segment of the genome, a pathway, an entire chromosome or the complete
genome. The approach is computationally fast and applicable to binary and complex
phenotypes. The methodology is evaluated in simulation studies and by applications
to a GWAS dataset from the COPDgene study. The simulation studies suggest that the
approach has sufficient power to test simultaneously all genotyped loci on the entire
genome or a specific chromosome.
3.2 Methods
The proposed test assesses whether there is significant clustering of causal variants
within a specified region. We consider both the level of associations between the variants
and the trait, and the location of the variants. The degree of association between a variant
and the phenotype is represented by the association p-values, which is easy to obtain
from any dataset and allows the application of our method to both quantitative traits and
dichotomous traits. To put this into a one-dimensional clustering problem, we need to
consider four aspects of the test:
1) What distance measure to use: the physical distance between two variants or a newly
defined distance measure.
2) Which SNVs to look at: the cut-off value for the p-values of the variants.
3) Whether to look at the distance to the nearest neighbor or the distances to the
neighboring variants, and how many neighboring variants should be considered in the
calculation of distances.
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4) How to quantify the difference between the distribution of the observed distances and
the distribution of distances under the null, i.e. what test to use.
3.2.1 Distance measure
The first three questions shown above refer to the choice of distance distribution.
Considering the absolute size of the physical distances between variants and the p-values
obtained from the association tests, our goal is to have a distance measure such that
the distance between two variants is small if the ”average” p-value of the two variants
is small, and if the physical distance between the two variants is small, relative to the
other variants. Thus, we consider the multiplication of the physical distance with the
association information rather than the addition of the two values to avoid the situation
where the ”average p-value” is overwhelmed by the physical distance. To obtain the
”average” degree of association of the two variants, multiplication of the two p-values is
also more suitable than addition since one large p-value would dominate a much smaller
p-value. We define a new distance measure D between two variants that combines the
p-value with the physical distance between the variants:
Di,j = disti,j∗
√
SiSj
where the subscript i and j refer to any two variants in the region of interest. The distance
measure is motivated by the fact that this distance equals the area below the geometric
average of the p-values of the two variants. Note that the distance distribution used
for testing and the actual test used in our method, as described below, depend only on
the relative value of the new distance measure between two variants comparing to the
other distances rather than the absolute value, and the physical distance between specific
variants is fixed in permutations. As a consequence, any monotonic function of (Si ∗ Sj)
(Eg. the square root) used in the definition of the distance measure will provide the same
test results. We use the square root here to have the absolute value of Di,j to lie in a
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reasonable range.
3.2.2 Cut-off values
There are two parameters that can be varied in the test: a cut-off value for the p-values –
P, such that only variants with p-values below P are considered in the test of clustering;
and the number of neighboring variants around each variant for calculating the distances
– R. We could use a p-value of 1 to include all the variants and consider the distances
from one variant to all the other variants in the region, but simulations suggest that this
is computationally costly and has relatively low power comparing to including only
variants with p-values below a threshold. Thus, a threshold on the p-value for selecting
variants is used. The nearest neighbor method is commonly used in clustering analysis,
and it requires less computational cost. However, it does not give much information on
the second, third, or higher level neighbors. Thus we consider both the distance to the
nearest neighbor and the distances to a pre-defined R number of neighboring variants in
the region.
In our analysis, this threshold of neighboring variants R and the cut-off value of p-values
P are set to be the values that correspond to specified quantiles of all the variants in the
region of interest. For example, we may specify the cut-off quantile for the p-values to
be 0.1%, which means the top 0.1% variants with the smallest p-values are included in
the analysis. If we specify the quantile threshold of neighboring variants R to be 1%, it
means that the number of neighboring variants used to calculate the distances from each
variant is 1% times N, where N is the total number of variants.
3.2.3 Test on the distance distribution
To test wether there is clustering of small p-values, the distribution of the distances be-
tween the variants needs to be compared to the distribution of the distances under the
null hypothesis in some way. The most popular nonparametric method to compare the
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empirical distribution of one sample with a specified distribution, or to compare the em-
pirical distributions of two samples, is the Kolmogorov-Smirnov (KS) statistic, defined
as:
Dn1,n2 = sup
x
|F1,n(x)− F2,n(x)|
where F1,n(x) = 1n
n∑
i=1
IXi≤x is the observed cumulative distribution function of the first
sample, and similarly F2,n(x) is the observed cumulative distribution function of the
second sample. The first sample, in our case, refers to the observed distances between
the variants. The second sample, refers to the distances between the variants obtained
under the null hypothesis using permutations.
We also considered an alternative approach, called the Bin test statistic as described
below, that extends the idea in [Kowalski et al., 2002] [Olson et al., 2005]. The Bin test
is a permutation test that compares the observed proportions of distances in ten given
intervals to the expected proportions of distances using the M statistic (referred to as the
Bin test):
M = (Prop− E(Prop))TS(−1)(Prop− E(Prop))
The distances between the variants obtained using permutations under the null are
ordered and put into 10 bins with equal size, therefore there are 10% of all the distances
in each of the 10 bins. Thus, E(Prop) is set to be a 10 × 1 vector of 10% in this statistic,
i.e. (0.1, 0.1, 0.1, 0.1, 0.1, 0.1, 0.1, 0.1, 0.1, 0.1). Then, the minimum and maximum of
the distances in each bin give the interval of distance of each bin. Prop is then the
10 × 1 vector of the proportions of the observed distances in these ten intervals. S(−1)
is the 10 × 10 Moore-Penrose generalized inverse of the variance covariance matrix of
the proportions of distances in the ten intervals from each permutation under the null.
The number of equally spaced bins could be varied, and unequally spaced bins could
be used, as discussed in [White et al., 2009]. We chose 10 equally spaced bins here to
simplify the problem, but further investigation is needed to evaluate the performance of
the statistic with other choices.
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For both the KS and the Bin tests, the null distribution of distances is obtained by
permuting the case and control status among the subjects, which conserves the linkage
disequilibrium (LD) between the variants.
Other distribution tests could also be used here, such as the Ansari-Bradley test. From a
limited number of simulations, the Ansari-Bradley test gives a moderate power that is
higher than the KS test, but does not perform as good as the Bin test (data not shown here).
3.3 Results
We assessed the performance of the KS test and the Bin test using simulations based
on the genotypes of the African American (AA) samples in the GWAS dataset of the
COPDgene study [Regan et al., 2011]. Also, the Bin test was applied to the chronic
obstructive pulmonary disease (COPD) status of both the African American samples and
the Non-Hispanic White (NHW) samples separately. There are 682945 SNPs included
for the 2569 AA samples (820 cases and 1749 controls), and 629027 SNPs included for
the 5351 NHW samples (2819 cases and 2532 controls), after the quality control (QC)
steps. We excluded variants with MAF < 0.01, high missing rate (above 5% for SNPs
with MAF ≥ 5%, and above 2% for SNVs with MAF ≤ 5%), HWE p-value < 10E − 3, and
concordance rate < 99% using 205 duplicated samples. Samples with call rate < 98.5%,
and mismatched gender and race were also excluded. Autosomal SNPs with HWE
p-value > 0.01, MAF > 0.05, and markers represented in Hapmap III were used for
Principal Component analysis. Eigenstrat was used to adjust for population substructure
for both AA and NHW samples to obtain the p-values of the Armitage trend test.
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3.3.1 Simulation results
Simulation results on entire chromosome
In our simulations, we used the genetic data on chromosome 7 from the COPDgene
study, but generated the case and control status according to our disease model. Principal
components were also included to adjust for the association p-values of the SNPs in the
simulation. Two different scenarios were considered. First, we selected nine SNPs on
chromosome 7 as the causal variants that reside close to each other, and considered both
protective and deleterious effects of the variants and different effect size. Two sets of
effect sizes are simulated for this scenario. For effect 1, the odds ratio of the nine SNPs
are (0.8, 1.1, 0.9, 1.2, 0.9, 1.2, 1.2, 1.5, 1.5); for effect 2, the odds ratio of the nine SNPs are
(0.8, 1.1, 0.8, 1.3, 0.9, 1.3, 1.2, 1.5, 1.5). Then given the effect size and the genotypes of the
samples in the COPDgene study, we generate the case and control status accordingly.
Second, we considered the possibility of having a lot of causal variants with small effect
size. Thus, 100 causal variants are chosen in proximity to each other on the chromosome
by randomly selecting 100 variants in a randomly selected region on the chromosome.
The effect sizes (odds ratio) are generated using a normal distribution with mean 1 and
standard deviation 0.05.
Sensitivity analysis was done to assess the effects of the p-value cut-off P, and the number
of neighbouring variants R, on the power and type I error of the Bin test. The results
and discussions are in Appendix B. According to the analysis, to achieve a good power,
SNPs with p-value in the top 0.5% percentile were included in the analysis, and 0.1% ∗N
neighbouring SNPs next to each SNP were used in the tests, where N is the total number
of SNPs in the dataset. Due to computational limitation, 2000 permutations were used in
each permutation set to maintain the type I error, as explained in our sensitivity analysis
(Appendix B). For each scenario, 200 simulations were generated to obtain the estimated
power and the type I error rate. The power of the test is the percentage of simulations
in which the permutation p-value is less than 0.05. The results of the Bin test are shown
in Table 3.1, as well as the power of the KS test, as a comparison. We observed a higher
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power of the Bin test comparing to the KS test in all the scenarios. Therefore, the Bin
test is recommended and is used in the calculation of the association p-values of the
chromosomes in the application section.
Table 3.1: The power of the tests for three scenarios, obtained from 200 simulations with
2000 permutations in each permutation set.
Effect1 Effect2 Effect3
Bin Test 0.920 0.990 0.345
KS Test 0.620 0.845 0.195
The power is the number of simulations with p-value less than 0.05. The effect sizes
(odds ratio) of the nine SNPs with the intercept at the front are Effect 1: (0.135, 0.8, 1.1,
0.9, 1.2, 0.9, 1.2, 1.2, 1.5, 1.5) and Effect 2: (0.135, 0.8, 1.1, 0.8, 1.3, 0.9, 1.3, 1.2, 1.5, 1.5) for
the first two columns. The MAF of the nine SNPs are (0.1740, 0.4914, 0.1734, 0.1244,
0.4673, 0.2552, 0.1098, 0.0309, 0.0728). For effect 3, 100 SNPs were chosen within a
random segment on the chromosome and are assigned with randomly generated effect
sizes from a normal distribution with mean 1 and standard deviation 0.05 with an
intercept odds of 1 in each simulation.
We also computed the type I error rate of the Bin test on three different autosomal
chromosomes by randomly generating the probability of having the disease for each
individual using an uniform distribution Unif(0, 0.5), and then randomly generated the
disease status for each sample using a Bernoulli distribution with these probabilities. It is
shown in Table 3.2 that the type I error rate is well-maintained with different LD patterns
on different chromosomes.
Table 3.2: The type I error rate of the test on chromosome 7, 10, and 22. 2000 permutations
were used and 200 replicates were generated to compute the type I error rate.
Chromosome 7 Chromosome 10 Chromosome 22
Bin Test 0.030 0.065 0.020
KS Test 0.035 0.025 0.040
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3.3.2 Application results
Results on each chromosome
The test was applied to the two subpopulations (AA and NHW) separately to see if there
is any chromosome that is significantly clustered with variants associated with COPD
status. Similar to the simulations, the cut-off value for the association p-value percentiles
was 0.5% , and the quantile of neighbouring SNPs around each SNP to be included in
the analysis was 0.1%. The p-values for testing for clustering on each chromosome were
obtained using a 2000 permutation set.
Association p-values of the Armitage trend test for the SNPs, adjusted for ancestry, were
computed for the AA and the NHW samples and are plotted in Figure 3.1 and 3.2 below.
It has been found from previous studies that loci in the FAM13A gene on chromosome 4
is susceptible to COPD [Cho et al., 2010] and there are studies indicating that loci at the
CHRNA3-CHRNA5-IREB2 locus on chromosome 15 and loci near HHIP on chromosome
4 may be related to COPD [Pillai et al., 2009] [Wilk et al., 2009]. For the AA samples,
no SNP is shown to be significantly associated with COPD, as shown in Figure 3.1.
However, from Figure 3.2 of the NHW samples, we observe that several SNPs reach the
significance level (5× 10−8) on chromosome 15, but none on chromosome 4.
Thus we applied our clustering method to both datasets to see if there is any chromosome
on which there is significant clustering of causal variants. The results are shown in Table
3.3. We found that for the NHW samples, both chromosome 4 and 15 are significantly
clustered with causal variants, with p-values less than 0.05/22 = 0.00227. However, in
the AA dataset, we do not observe any p-value < 0.00227 for chromosome 4, which may
be explained by the smaller sample size in the AA dataset.
Note that no covariate was available to us in our initial analysis. Later with information
on smoking status, gender and age at enrolment included in the analysis, several SNPs on
chromosome 4 and 15 are shown to be significantly associated with the COPD affection
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Figure 3.1: The Manhattan plot of the adjusted p-values of the SNPs in the AA dataset.
Figure 3.2: The Manhattan plot of the adjusted p-values of the SNPs in the NHW dataset.
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status. However, the above analysis shows the additional significance region obtained
using our method when the other information is not available.
Table 3.3: The p-value of the 22 chromosomes of the two populations in the COPDgene
GWAS dataset. With Bonferroni correction, the p-values should be compared with
0.00227.
Chromosome P-value AA (2000 perm set) NHW (2000 perm set)
1 0.76500 0.13450
2 0.82025 0.09050
3 0.32900 0.04050
4 0.12700 0.00125
5 0.16286 0.16650
6 0.08538 0.71695
7 0.47025 0.46038
8 0.44808 0.08975
9 0.24500 0.70183
10 0.87500 0.46525
11 0.32186 0.01950
12 0.97142 0.15056
13 0.12088 0.93250
14 0.79725 0.49900
15 0.51375 0.00150
16 0.07438 0.13082
17 0.88933 0.06700
18 0.37150 0.72600
19 0.42408 0.73575
20 0.88800 0.62363
21 0.96375 0.97567
22 0.08363 0.24056
Results for genes on chromosome 4
In this section, we applied the proposed test as a gene-based test to a number of selected
genes on chromosome 4. The distance distribution of chromosome 4 is shown in Figure
3.3 to compare to the distance distribution obtained using 250 permutations under the
null. We observe the largest difference between the distributions at distance D around
2600. Figure 3.4 shows the physical position of
the SNPs with their p-values on the y-axis for the observed phenotype and a generated
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Figure 3.3: The distance distributions of the observed distances D between two variants
and the distance distribution of the distances obtained using 250 permutations under the
null.
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phenotype from one permutation. The SNPs are colored according to the number of
distances D to the neighboring SNPs that are less than 2600. The more number of neigh-
boring SNPs with D < 2600, the deeper the red color. The two clusters shown here reside
in FAM13A and the upstream region HHIP on chromosome 4q31. A less obvious cluster
reside at the loci 4p15.31. To demonstrate the performance, we applied our method again
on these regions and another COPD-candidate gene PPARG on chromosome 3. All SNPs
on each gene are included and the distances to all SNPs on the gene are used. 10000
permutations are done for each case. The p-values obtained for five genes are shown
in Table 3.4 and the associations of FAM13A and the region at 4q31.21 with COPD are
shown to be significant by our method. We also test the variants in HHIP and found no
significant association. These findings are consistent with GWAS results in lung function
in COPD identifying the region upstream of HHIP, as well as data demonstrating a
functional impact of these variants in COPD [Zhou et al., 2012].
Table 3.4: The p-value of the genes FAM13A, KRT18P51(psudogene), HHIP, PPARG and
LOC729006.
Gene FAM13A KRT18P51 HHIP PPARG LOC729006
P-value < 0.00001 < 0.00001 0.34745 0.96516 0.001
Result on the entire genome
We have also applied the test to the entire genome to see if there is any region in the
genome that is clustered with the causal variants. Due to the computational cost, a
much smaller p-value cut-off is used (0.025%) and a much smaller threshold for the
neighboring SNP is used (0.005%). With 2000 permutations set, the p-value is < 0.0005
for the entire genome, showing strong significance of association between the genome
and the phenotype. Currently, there is no other multi-loci association method that could
test the association of the entire genome with the phenotype. This application shows the
potential of our method for testing large genomic regions when no significant association
is found for univariate tests. One possible way to search for the associated loci with the
phenotype is to conduct a binary search using our method. Interested readers could refer
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Figure 3.4: The p-values of the SNPs versus their physical positions on chromosome 4.
The p-values of the SNPs from one permutation is also shown in blue circle for compari-
son. The black circles are colored from yellow to red according to the number of distances
D that are less than 2600 between each SNP to their neighboring SNPs. The deeper the
red color, the larger number of distances D that are less than 2600.
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to the Appendix for some discussion about the procedure.
3.4 Discussion
In summary, we proposed here an approach for the detection of clustering of causal
variants on a genomic region of any size. Many existing methods collapse the effects
of variants across a region or a gene, however, very few of them utilizes the physical
location of these variants and many would suffer lost of power when too many variants
are included. Simulations and application results suggest that our approach provides
sufficient power to detect associated genomic regions with complex disease.
The same idea of test of clustering could be applied to sequencing data, where thousands
of variants would be available for each gene. For variants that are extremely rare,
the univariate p-value may include only random noise, thus other measure of the
association at each variant need to be considered. i.e. standard analysis approaches for
rare variant analysis. Moreover, the genomic region could refer to the genes in the same
pathway [Wang et al., 2007], thus whether there is significant clustering of small p-values
in each pathway could be examined.
However, there are several drawbacks we need to consider. Since permutation is used
to obtain the p-value of the test statistic, there is extensive computational cost if the test
is applied to a large number of small regions, which requires more number of permuta-
tions. The power may also be compromised if the regions are extremely small, limiting
the possibility of clusters and their detection, and if the number of regions to be tested
are extremely large due to multiple testing problem. Right now the method is limited to
population-based studies since permutation of the affections status is used to evaluate the
p-values, but since the associations are represented by p-values, which could be obtained
from either population-based association tests, or family-based association tests, there is
potential to extend the approach to family-based association studies.
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Appendix A
Asymptotic distribution of Topt
A.1 Derivation of the estimated expected value and vari-
ance of the statistics
Under the assumption of Hardy-Weinberg equilibrium, and assuming that there is no LD
between the loci, the mean and variance of S1 and S2 can be derived analytically based
on the estimated allele frequencies. They are given by:
E(S1) = E(
m∑
i=1
(Xi − 2pi)) =
m∑
i=1
(E(Xi)− 2pi) = 0
V ar(S1) = V ar(
m∑
i=1
(Xi − 2pi)) =
m∑
i=1
V ar(Xi − 2pi) =
m∑
i=1
(2pi(1− pi))
E(S2) = E(
m∑
i=1
(|Xi − 2pi|)) =
m∑
i=1
(E(|Xi − 2pi|)) =
m∑
i=1
(4pi(1− pi)2)
V ar(S2) = V ar(
m∑
i=1
(|Xi − 2pi|)) =
m∑
i=1
V ar(|Xi − 2pi|) =
m∑
i=1
(2pi(1− pi)(1− 8pi(1− pi)3))
Then the standardized test statistics based on the estimated allele frequencies are:
T1 =
[
m∑
i=1
(Xi − 2pi)]2
m∑
i=1
(2pi(1− pi))
(A.1)
T2 =
[
m∑
i=1
(|Xi − 2pi| − (4pi(1− pi)2))]2
m∑
i=1
(2pi(1− pi)(1− 8pi(1− pi)3))
(A.2)
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A.2 Derivation of the correlation of R1 and R2 and how to
obtain the asymptotic distribution of Topt
Let ρ = Corr(R1, R2) = Cov(R1, R2). First, we need to calculate ρˆ using the observed data:
Cov(S1, S2) = E(S1S2)− E(S1)E(S2) = E(S1S2) = E[
m∑
i=1
(Xi − E(Xi))
m∑
i=1
|Xi − E(Xi)|]
=
m∑
i=1
m∑
j=1,j 6=i
E[(Xi − E(Xi))|Xj − E(Xj)|] +
m∑
i=1
E[(Xi − E(Xi))|Xi − E(Xi)|]
If Xi and Xj are independent and since E(S1) = 0,
Cov(S1, S2) =
m∑
i=1
m∑
j=1,j 6=i
E[(Xi − E(Xi))]E[|Xj − E(Xj)|] +
m∑
i=1
E[(Xi − E(Xi))|Xi − E(Xi)|]
=
m∑
i=1
E[(Xi − E(Xi))|Xi − E(Xi)|]
Ĉov(S1, S2) =
m∑
i=1
[(−4pˆi2) ∗ (1− pˆi)2 + (1− 2pˆi)2 ∗ (2pˆi(1− pˆi)) + (2− 2pˆi)2 ∗ pˆi2]
=
m∑
i=1
2pˆi(1− pˆi)(1− 2pˆi)2
Then,
ρ = Corr(R1, R2) = Cov(R1, R2) = Cov(
S1 − E(S1)√
V ar(S1)
,
S2 − E(S2)√
V ar(S2)
)
=
1√
V ar(S1)
√
V ar(S2)
Cov(S1, S2)
ρˆ =
m∑
i=1
2pˆi(1− pˆi)(1− 2pˆi)2√
m∑
i=1
(2pˆi(1− pˆi))
m∑
i=1
(2pˆi(1− pˆi)(1− 8pˆi(1− pˆi)3))
If there are LD between the SNPs,
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Ĉov(S1, S2) =
m∑
i=1
m∑
j=1,j 6=i
 2∑
Xi=0
2∑
Xj=0
(Xi − E(Xi))|Xj − E(Xj)|P̂i,j(Xi, Xj)

+
m∑
i=1
E[(Xi − E(Xi))|Xi − E(Xi)|]
=
m∑
i=1
m∑
j=1,j 6=i
 2∑
Xi=0
2∑
Xj=0
(Xi − E(Xi))|Xj − E(Xj)|P̂i,j(Xi, Xj)

+
m∑
i=1
2pˆi(1− pˆi)(1− 2pˆi)2
=
m∑
i=1
m∑
j=1
 2∑
Xi=0
2∑
Xj=0
(Xi − 2 pˆi)|Xj − 2 pˆj|P̂i,j(Xi, Xj)
+ m∑
i=1
2pˆi(1− pˆi)(1− 2pˆi)2
where P̂i,j(Xi, Xj) and pˆi needs to be estimated using the dataset.
Then,
ρˆ =
Ĉov(S1, S2)√
V̂ ar(S1)
√
V̂ ar(S2)
=
Ĉov(S1, S2)√
m∑
i=1
V̂ ar(∆Xi) +
m∑
i=1
∑
j 6=i
Ĉov(∆Xi,∆Xj)
√
m∑
i=1
V̂ ar(|∆Xi|) +
m∑
i=1
∑
j 6=i
Ĉov(|∆Xi|, |∆Xj|)
where
Ĉov(∆Xi,∆Xj) =
2∑
Xi=0
2∑
Xj=0
(Xi − 2 pˆi)(Xj − 2 pˆj)P̂i,j(Xi, Xj)
Ĉov(|∆Xi|, |∆Xj|) =
2∑
Xi=0
2∑
Xj=0
|Xi − 2 pˆi||Xj − 2 pˆj|P̂i,j(Xi, Xj)
V̂ ar(∆Xi) =
m∑
i=1
(2 pˆi(1− pˆi))
V̂ ar(|∆Xi|) =
m∑
i=1
(2 pˆi(1− pˆi)(1− 8 pˆi(1− pˆi)3))
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Therefore, since both R1 and R2 are also asymptotically distributed as N(0, 1), we could
simulate the asymptotic distribution of Topt for a particular dataset in the following steps.
Suppose we use sample size n = 100000.
1. Suppose there are two random variables Z andW following two independent standard
normal distributions. We generate n data points for the two random variables.
2. Create a new variable U = ρZ +
√
(1− ρ2) W, then U also has a standard normal
distribution. Also,
Corr(Z,U) = Cov(Z,U) = Cov(Z, ρZ +
√
(1− ρ2)W ) = Cov(Z, ρZ) = ρ
3. We generate the data points of U using the data points generated for Z and W .
4. We generate the data points of T using T = max(Z2, U2).
Then, the simulated distribution of T is just the asymptotic distribution of Topt for the
dataset.
For the simulation of the asymptotic distribution of the test statistic in the simulation
studies, we found that the asymptotic distribution does not vary much with the estima-
tion of the correlation coefficient in the presence of LD between the markers and under
the assumption of no LD between the markers. Thus, we decided to use the estimate
of the correlation of R1 and R2 under the assumption of no LD between the markers to
save computational time. From the results section we can see that this approximation is
acceptable in terms of power and type I error.
A.3 Estimated Power of T1 and T2
Suppose the allele frequencies of the study population are pi, i = 1, ...m for the m SNPs,
and the allele frequencies for the subpopulation that the outlier is from are pdi where
pdi = pi + δi for i = 1, ...m markers, and assume that δi are independently and identically
distributed, then we can analytically obtain the power of the statistics T1 and T2 and look
at how the power changes as a function of pi.
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Suppose the outlier is from the subpopulation d with allele frequencies pdi for i = 1, ...,m
markers, then the expected values of R1 and R2 can be obtained as the following:
Ed(R1) = Ed

m∑
i=1
(Xi − 2pi)√
m∑
i=1
(2pi(1− pi))
 = Ed
[
m∑
i=1
(Xi − 2pi)
]
√
m∑
i=1
(2pi(1− pi))
=
m∑
i=1
Ed(Xi − 2pi)√
m∑
i=1
(2pi(1− pi))
=
m∑
i=1
−2 pi (1− pi − δi)2 + 2 (1− 2 pi) (pi + δi) (1− pi − δi) + (2− 2 pi) (pi + δi)2√
m∑
i=1
(2pi(1− pi))
=
√
2
m∑
i=1
δi√
m∑
i=1
pi (1− pi)
Thus, if there is a one-direction difference in the allele frequencies, i.e. E(δi) 6= 0, then
T1 = R
2
1 has power to detect the population substructure in the dataset. Figure A.1 shows
how the expected value of R1 changes as a function of δi and average pi, which indicates
the change in power as a function of δi and pi. As expected, the power is much larger for
sequence data.
Figure A.1: The average power of R1 as a function of δi and pi.
Similarly we can obtain the expected value ofR2 for the outlier as the following: Ed(R2) =
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Ed

[
m∑
i=1
|Xi−2pi|−(4pi(1−pi)2)
]
√
m∑
i=1
(2pi(1−pi)(1−8pi(1−pi)3))

=
Ed
[
m∑
i=1
|Xi−2pi|−(4pi(1−pi)2)
]
√
m∑
i=1
(2pi(1−pi)(1−8pi(1−pi)3))
=
m∑
i=1
[Ed(|Xi−2pi|)−(4pi(1−pi)2)]√
m∑
i=1
(2pi(1−pi)(1−8pi(1−pi)3))
=
[
m∑
i=1
[2 pi(1−pi−δi)2+2 (1−2 pi)(pi+δi)(1−pi−δi)+(2−2 pi)(pi+δi)2−(4pi(1−pi))]]√
m∑
i=1
(2pi(1−pi)(1−8pi(1−pi)3))
=
m∑
i=1
[4 pi δ2i+(8 p2i−8 pi+2) δi]√
m∑
i=1
(2 pi(1−pi)(1−8 pi (1−pi)3))
=
m∑
i=1
4 pi δ
2
i√
m∑
i=1
(2 pi(1−pi)(1−8 pi (1−pi)3))
+
m∑
i=1
(8 p2i−8 pi+2) δi√
m∑
i=1
(2 pi(1−pi)(1−8 pi (1−pi)3))
This formula shows clearly that even if there is two-direction difference between the
allele frequencies in the two populations, i.e. E(δi) = 0, R2 still has power since it
includes the δ2i term which is not expected to be 0. Figure A.2 shows how the expected
values of R2 changes as a function of δi and pi, and again if E(δi) 6= 0, it shows that the
power increases rapidly as the average allele frequency becomes much smaller than 0.01.
If E(δi) = 0, the expected test statistic changes with the term in front of δ2i , and actually
increases with pi as shown in Figure A.3.
We have also considered test statistics with higher moments of ∆Xi = Xi − 2 pi, and
looked at how the power changes as a function of the moment and pi. Let
Rq =
[
m∑
i=1
(Xi − 2 pi)q − E [(Xi − 2 pi)q]√
m∑
i=1
V ar((Xi − 2 pi)q)
Then the expected value of Rq for the outlier is:
Ed(Rq) = Ed
 [ m∑i=1(Xi−2 pi)q−E[(Xi−2 pi)q ]√
m∑
i=1
V ar((Xi−2 pi)q)
 = [ m∑i=1Ed[(Xi−2 pi)q ]−E[(Xi−2 pi)q ]√
m∑
i=1
V ar((Xi−2 pi)q)
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Figure A.2: The average power of R2 as a function of δi and pi.
Figure A.3: The average power of R2 as a function of pi if E(δi) = 0.
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=[
m∑
i=1
(−2 (1−2 pi)qpi+2 (1−2 pi)q(1−pi)+(−2 pi)q(−2+2 pi)+2 (2−2 pi)qpi)δi
]
√
m∑
i=1
V ar((Xi−2 pi)q)
+
[
m∑
i=1
((−2 pi)q−2 (1−2 pi)q+(2−2 pi)q)δi2
]
√
m∑
i=1
V ar((Xi−2 pi)q)
where
V ar [(Xi − 2 pi)q)] = (−2 pi)q (1− pi)2 + 2 (1− 2 pi)q pi (1− pi) + (2− 2 pi)q pi2
If E(δi) = 0, the term in front of δ2i determines the power, thus we plot this term as a
function of q and pi and we observe that for different MAF level, with q greater than a
threshold approximately, the expected statistic does not increase as rapidly as for q less
or equal to that threshold. For a fixed moment q, the expected value of Tq = R2q increases
very fast as the allele frequency decreases.
From Figure A.4, it seems we should use greater moment to achieve better power, how-
ever, in our simulation to compare the power of the test statistics based on
m∑
i=1
|∆Xi| and
m∑
i=1
(∆Xi)
2, we obtain better power with
m∑
i=1
|∆Xi|. We believe that this is due to the fact
that most of the power for the scores based on higher moments is from the subjects with
homozygous rare allele type. However, the number of subjects with homozygous rare
alleles is very limited in real datasets. Also, there is not much contribution from subjects
with heterozygous genotype for scores based on higher moments. Thus, with limited
number of subjects in the rare variant dataset as in most real-world scenarios, the power
of
m∑
i=1
|∆Xi| is higher. Thus, we decide to use
m∑
i=1
|∆Xi| rather than
m∑
i=1
(∆Xi)
2, or even
higher moments.
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Figure A.4: The average power of R2 as a function of pi if E(δi) = 0.
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Appendix B
Sensitivity analysis of the Bin test
B.1 Sensitivity analysis
There are two variables to be investigated in the sensitivity analysis: the p-value cut-off
percentile – P, the pre-defined proportion of neighboring variants for calculating the
distances – R.
In our implementation, there are M permutations in each permutation set. More specif-
ically, this means that a pre-defined M number of permutations are first generated to
calculate the p-value of clustering, then another set of M permutations are obtained to
test this p-value (two-sided Binomial test). If the p-value is rejected using the second
set of M permutations, a new set of M permutations are generated in addition to the
previous ones to obtain the updated p-value and another set of M permutations are
used to test this p-value, this continues until the p-value is not rejected by the last set of
M permutations. This pre-defined number of permutations M are set to be 2000 in the
sensitivity analysis of the power and type I error. If insufficient number of permutations
are used, the type I error would be inflated.
We are interested in the effect of the p-value cut-off P, and the range threshold R for the
number of neighboring variants for the calculation of distances on the power and type I
error rate of the test.
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B.1.1 Power
The same simulation model and parameters are used here as scenario 1 described in the
simulation section. The effect sizes are the same as for Effect 1 in Table 3.1. Three levels
of the p-value cut-off are considered: 0.5%, 1%, and 5%. Three levels of the threshold for
the number of neighboring variants used in the calculation
Table B.1: The power of the Bin test with different quantiles for the p-value cut-off thresh-
old P and the number of neighboring SNP for calculating the distances.
Power 0.5% 1% 5%
0.01% 0.77 0.64 0.45
0.05% 0.89 0.79 0.60
0.1% 0.91 0.87 0.77
2000 permutation set is used in each replicate and 100 replicates are used in each case.
The columns correspond to three quantiles for p-value cut-off. The rows correspond to
three quantiles for the number of neighboring variants to be used for calculating
distances.
of distances are considered: 0.01%, 0.05%, and 0.1%. Note that the values are the quantiles
among all the SNPs rather than the absolute value. The results are shown in Table B.1
and we observe that as the p-value cut-off P decreases (a smaller number of variants
would be included), the power of the test increases. This is expected because the causal
variants with more significant p-value would give more information and less noise in
the calculation. However, if only the top p-values are included, causal variants with
relatively small p-value in proximity to other causal variants would be ignored, which
in turn would decrease the power. Also, as the threshold for the number of neighboring
variants R increases, the power of the test increases as expected, but more computation
and time would be needed.
B.1.2 Type I Error
With 2000 permutation sets, the type I error is mostly well-maintained, as in Table B.2.
However, with a smaller number of permutations used, we do observe an increase in
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type I error as the p-value cut-off P decreases and as the threshold R for the number of
neighboring SNPs increases (data not shown). Thus, from our simulations, it is recom-
mended to use a larger number of permutations to obtain the p-value for a small p-value
cut-off P and large threshold R for the number of neighboring SNPs.
Table B.2: The type I error of the Bin test with different p-value cut-off threshold P and
different range R for the neighboring SNP for calculating the distances.
Type I Error 0.5% 1% 5%
0.01% 0.04 0.04 0.02
0.05% 0.06 0.04 0.03
0.1% 0.02 0.04 0.06
2000 permutation set is used in each replicate and 100 replicates are used. The columns
correspond to three quantiles for p-value cut-off. The rows correspond to three quantiles
for the number of neighboring variants to be used for calculating distances.
B.2 Binary search for the associated region
One advantage of our test is that it could detect a loci or a gene that is clustered with
causal variants in a large region, thus it could be used in a binary search for the associated
region with the phenotype. The idea is to test each chromosome separately first, then
do a binary search for the chromosome with significant p-values. A tentative procedure is:
1) Define the minimum size of a loci to be tested. Check if the first and the second half
of the region are greater than this minimum size. If not, this region should be returned
as the associated region with the phenotype. Otherwise, the first and second half of the
region are tested separately.
2) If none of the half of the region is significant, the middle region should be tested, go to
step 3); If any of the half of the region is significant, repeat step 1) for the significant region.
3) Define a maximum size of a loci to be tested and a step size. If the middle region with
the predefined minimum size is tested to be significant, report this region. Otherwise,
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the middle region is increased at the two end with the step size and tested again until
either significant result is obtained or the maximum size is reached. If no significant
region found even for the maximum size, report the last region with a significant result.
If significant result if obtained, report this middle region.
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